James F. White, Ph.D., President and Chief Executive Officer

Dr. White received his Ph.D. in Pharmacology and Toxicology from Purdue University.  Following completion of his work at Purdue, Dr. White joined Eli Lilly and Company as a Senior Toxicologist, where he was responsible for the toxicological evaluation of several new drugs targeted for cardiovascular disease, central nervous system disorders and cancer.  Over a 20 year career at Lilly, Dr. White held several senior management positions in the company’s central nervous system drug discovery and development divisions.   In 2001, Dr. White joined Hypnion, Inc., a biotech company in the Boston-area as Executive Vice President of Research and Development and Chief Operating Officer.  In that role, he led a multi-disciplinary team to discover and develop new non-addicting sleep and wake promoting medications.  He joined CoLucid as President and CEO in 2006.  Dr. White also serves as a member of the Board of Directors of CoLucid.